Form 4 Tracker
CYTOKINETICS INC
CYTK

92 insider filings · Latest: Oct 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 28, 2024Oct 28 8:12 PMWENDELL WIERENGA
Proposed Sale
4,452$52.25$232.6K—

View →

Oct 15, 2024Oct 15 8:32 PMFADY MALIK
Proposed Sale
7,300$54.19$395.6K—

View →

Oct 9, 2024Oct 9 8:08 PMROBERT BLUM
Proposed Sale
5,000$55.61$278.1K—

View →

Oct 1, 2024Oct 1 8:21 PMFADY MALIK
Proposed Sale
7,300$52.10$380.3K—

View →

Sep 30, 2024Sep 30 8:06 PMROBERT BLUM
Proposed Sale
5,000$52.14$260.7K—

View →

Sep 17, 2024Sep 17 8:03 PMFADY MALIK
Proposed Sale
7,300$56.77$414.4K—

View →

Sep 16, 2024Sep 16 8:29 PMROBERT BLUM
Proposed Sale
5,000$55.99$280.0K—

View →

Sep 9, 2024Sep 9 8:12 PMB LYNNE PARSHALL
Proposed Sale
5,000$54.92$274.6K—

View →

Sep 3, 2024Sep 3 8:08 PMROBERT BLUM
Proposed Sale
5,000$57.03$285.1K—

View →

Sep 3, 2024Sep 3 8:07 PMFADY MALIK
Proposed Sale
7,384$57.01$421.0K—

View →

Aug 26, 2024Aug 26 8:14 PMB LYNNE PARSHALL
Proposed Sale
5,000$57.26$286.3K—

View →

← Previous

Page 7 of 7

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 12, 2026Oct 13 8:00 PMRobert I BlumDirector, President & CEO
Option Exercise
7,500$10.60141,745(D)

View →

Oct 6, 2026Oct 6 8:25 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8019,886(D)

View →

Sep 28, 2026Sep 28 8:54 PMRobert I BlumDirector, President & CEO
Option Exercise
7,500$10.60149,245(D)

View →

Sep 22, 2026Sep 22 10:14 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8023,386(D)

View →

Sep 14, 2026Sep 15 9:20 PMRobert I BlumDirector, President & CEO
Option Exercise
7,500$10.60156,745(D)

View →

Sep 8, 2026Sep 8 8:38 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8026,886(D)

View →

Aug 31, 2026Aug 31 8:57 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
10,000$23.260(D)

View →

Aug 31, 2026Aug 31 8:55 PMRobert I BlumDirector, President & CEO
Option Exercise
7,500$10.60164,245(D)

View →

Aug 18, 2026Aug 18 8:38 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8030,386(D)

View →

Aug 10, 2026Aug 10 9:11 PMRobert I BlumDirector, President & CEO
Option Exercise
7,500$10.60171,745(D)

View →

Jul 30, 2026Jul 30 8:26 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
14,000$23.2610,000(D)

View →

Jul 27, 2026Jul 27 8:33 PMRobert I BlumDirector, President & CEO
Option Exercise
7,500$10.60179,245(D)

View →

Jul 21, 2026Jul 23 8:09 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8033,886(D)

View →

Jul 13, 2026Jul 14 7:34 PMRobert I BlumDirector, President & CEO
Option Exercise
7,490$10.60186,745(D)

View →

Jul 7, 2026Jul 7 9:06 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8037,386(D)

View →

Jul 1, 2026Jul 2 9:19 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,000$23.2624,000(D)

View →

Jul 1, 2026Jul 2 9:17 PMSung LeeEVP, Chief Financial Officer
Option Exercise
1,112$48.5126,709(D)

View →

Jun 24, 2026Jun 29 10:05 PMSung LeeEVP, Chief Financial Officer
Option Exercise
38,730$48.5127,821(D)

View →

Jun 29, 2026Jun 29 9:23 PMSung LeeEVP, Chief Financial Officer
Option Exercise
3,134$48.5139,681(D)

View →

Jun 23, 2026Jun 23 9:41 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8040,886(D)

View →

Page 1 of 3

Next →